BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 27098518)

  • 1. Kruppel-like factor 4 (KLF-4) inhibits the epithelial-to-mesenchymal transition and proliferation of human endometrial carcinoma cells.
    Wang X; Li X; Huang C; Li L; Qu H; Yu X; Ni H; Cui Q
    Gynecol Endocrinol; 2016 Sep; 32(9):772-776. PubMed ID: 27098518
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Krüppel-Like Factor 4 Inhibits the Transforming Growth Factor-β1-Promoted Epithelial-to-Mesenchymal Transition via Downregulating Plasminogen Activator Inhibitor-1 in Lung Epithelial Cells.
    Sun F; Hu K
    Dis Markers; 2015; 2015():473742. PubMed ID: 26839446
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tumor-suppressive role of Kruppel-like factor 4 (KLF-4) in colorectal cancer.
    Xiu DH; Chen Y; Liu L; Yang HS; Liu GF
    Genet Mol Res; 2017 Feb; 16(1):. PubMed ID: 28218782
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metformin Increases E-cadherin in Tumors of Diabetic Patients With Endometrial Cancer and Suppresses Epithelial-Mesenchymal Transition in Endometrial Cancer Cell Lines.
    Laskov I; Abou-Nader P; Amin O; Philip CA; Beauchamp MC; Yasmeen A; Gotlieb WH
    Int J Gynecol Cancer; 2016 Sep; 26(7):1213-21. PubMed ID: 27643646
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Golgi phosphoprotein 3 (GOLPH3) promotes endometrial carcinoma cell invasion and migration by regulating the epithelial-mesenchymal transition.
    Wen Y; Tan X; Wu X; Wu Q; Qin Y; Liang M; Ran G; Gu H; Xie R
    Cancer Biomark; 2019; 26(1):21-30. PubMed ID: 31322544
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Autocrine motility factor promotes epithelial-mesenchymal transition in endometrial cancer via MAPK signaling pathway.
    Li Y; Che Q; Bian Y; Zhou Q; Jiang F; Tong H; Ke J; Wang K; Wan XP
    Int J Oncol; 2015 Sep; 47(3):1017-24. PubMed ID: 26201353
    [TBL] [Abstract][Full Text] [Related]  

  • 7. TRP channel expression correlates with the epithelial-mesenchymal transition and high-risk endometrial carcinoma.
    Van den Eynde C; De Clercq K; Van Bree R; Luyten K; Annibali D; Amant F; Han S; Van Nieuwenhuysen E; Baert T; Peeraer K; Voets T; Van Gorp T; Vriens J
    Cell Mol Life Sci; 2021 Dec; 79(1):26. PubMed ID: 34936030
    [TBL] [Abstract][Full Text] [Related]  

  • 8. TMEFF2 is a novel prognosis signature and target for endometrial carcinoma.
    Gao L; Nie X; Zheng M; Li X; Guo Q; Liu J; Liu Q; Hao Y; Lin B
    Life Sci; 2020 Feb; 243():116910. PubMed ID: 31610211
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of KLF17 as a novel epithelial to mesenchymal transition inducer via direct activation of TWIST1 in endometrioid endometrial cancer.
    Dong P; Kaneuchi M; Xiong Y; Cao L; Cai M; Liu X; Guo SW; Ju J; Jia N; Konno Y; Watari H; Hosaka M; Sudo S; Sakuragi N
    Carcinogenesis; 2014 Apr; 35(4):760-8. PubMed ID: 24220291
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Preliminary investigation of the expression and functions of insulin receptor isoforms in endometrial carcinoma].
    Zhang G; Li XP; Wang JL; Wei LH
    Zhonghua Fu Chan Ke Za Zhi; 2012 Nov; 47(11):839-45. PubMed ID: 23302125
    [TBL] [Abstract][Full Text] [Related]  

  • 11. miR‑215 promotes epithelial to mesenchymal transition and proliferation by regulating LEFTY2 in endometrial cancer.
    Gao X; Cai Y; An R
    Int J Mol Med; 2018 Sep; 42(3):1229-1236. PubMed ID: 29845221
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CCL20 mediates RANK/RANKL-induced epithelial-mesenchymal transition in endometrial cancer cells.
    Liu Y; Wang J; Ni T; Wang L; Wang Y; Sun X
    Oncotarget; 2016 May; 7(18):25328-39. PubMed ID: 27015366
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The cigarette smoke components induced the cell proliferation and epithelial to mesenchymal transition via production of reactive oxygen species in endometrial adenocarcinoma cells.
    Kim SM; Hwang KA; Choi DW; Choi KC
    Food Chem Toxicol; 2018 Nov; 121():657-665. PubMed ID: 30236600
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic Role of Krüppel-Like Factors 5, 9, and 11 in Endometrial Endometrioid Cancer.
    Viola L; Londero AP; Bertozzi S; Orsaria M; Marzinotto S; Antoniazzi F; Renda V; Cinel J; Fruscalzo A; Lellé RJ; Mariuzzi L
    Pathol Oncol Res; 2020 Oct; 26(4):2265-2272. PubMed ID: 32451988
    [TBL] [Abstract][Full Text] [Related]  

  • 15. S100A4 promotes endometrial cancer progress through epithelial-mesenchymal transition regulation.
    Hua T; Liu S; Xin X; Cai L; Shi R; Chi S; Feng D; Wang H
    Oncol Rep; 2016 Jun; 35(6):3419-26. PubMed ID: 27109209
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Krüppel-like factors 4 and 5 expression and their involvement in differentiation of oral carcinomas.
    Shibata M; Chiba T; Matsuoka T; Mihara N; Kawashiri S; Imai K
    Int J Clin Exp Pathol; 2015; 8(4):3701-9. PubMed ID: 26097551
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Promotion of epithelial-mesenchymal transition by Frizzled2 is involved in the metastasis of endometrial cancer.
    Bian Y; Chang X; Liao Y; Wang J; Li Y; Wang K; Wan X
    Oncol Rep; 2016 Aug; 36(2):803-10. PubMed ID: 27373314
    [TBL] [Abstract][Full Text] [Related]  

  • 18. DACH1 suppresses epithelial to mesenchymal transition (EMT) through Notch1 pathway and reverses progestin resistance in endometrial carcinoma.
    Zhou Q; Li W; Kong D; Liu Z; Shi Z; Ma X; Li Y; Jiang J
    Cancer Med; 2019 Aug; 8(9):4380-4388. PubMed ID: 31215145
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tamoxifen represses miR-200 microRNAs and promotes epithelial-to-mesenchymal transition by up-regulating c-Myc in endometrial carcinoma cell lines.
    Bai JX; Yan B; Zhao ZN; Xiao X; Qin WW; Zhang R; Jia LT; Meng YL; Jin BQ; Fan DM; Wang T; Yang AG
    Endocrinology; 2013 Feb; 154(2):635-45. PubMed ID: 23295740
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dysregulation of Krüppel-like factor 12 in the development of endometrial cancer.
    Ding L; Ding Y; Kong X; Wu J; Fu J; Yan G; Zhou H
    Gynecol Oncol; 2019 Jan; 152(1):177-184. PubMed ID: 30482501
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.